Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 3/2007

01.06.2007

Experimental Evaluation of Early and Long-Term Effects of Microparticle Embolization in Two Different Mini-Pig Models. Part II: Liver

verfasst von: S. Stampfl, U. Stampfl, C. Rehnitz, Ph. Schnabel, S. Satzl, P. Christoph, C. Henn, F. Thomas, G. M. Richter

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate trisacryl-gelatin microspheres (40–120 μm) for acute and chronic tissue embolization in mini-pig livers.

Methods

Thirteen animals were divided into four groups: group 1 (n = 3), total arterial bed occlusion with acute procedure; groups 2 to 4, chronic superselective embolization with follow-up of 1 week (group 2, n = 1), 4 weeks (group 3, n = 4) or 14 weeks (group 4, n = 5). Key endpoints were homogeneity and particle distribution in acute embolizations (group 1) and necrosis and inflammation in chronic embolizations (groups 2–4) as assessed microscopically and angiographically.

Results

After liver embolization, parenchymal necrosis did not occur; only signs of vessel wall disintegration were evident. The bile ducts remained intact. A distinct foreign body reaction with sparse leukocytic infiltration and giant cells was found at 14 weeks, but no signs of major inflammation were found. Particles were seen at the presinusoidal level, but no particle transportation into the sinusoids was observed.

Conclusions

Embolization in mini-pig livers, using small trisacryl-gelatin microspheres, results in vessel fibrosis without parenchymal or bile duct necrosis. The most likely explanation for preservation of the parenchyma is portal inflow. Small trisacryl-gelatin microspheres may be ideal as an adjunct for chemoembolization.
Literatur
1.
Zurück zum Zitat Pelletier G, Roche A, Ink O, Anciaux ML, Derhy S, Rougier P, Lenoir C, Attali P, Etienne JP (1990) A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 11:181–184PubMedCrossRef Pelletier G, Roche A, Ink O, Anciaux ML, Derhy S, Rougier P, Lenoir C, Attali P, Etienne JP (1990) A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 11:181–184PubMedCrossRef
2.
Zurück zum Zitat Pelletier G, Ducreux M, Gay F, Luboinski M, Hagege H, Dao T, Van Steenbergen W, Buffet C, Rougier P, Adler M, Pignon JP, Roche A (1998) Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial. Groupe CHC. J Hepatol 29:129–134PubMedCrossRef Pelletier G, Ducreux M, Gay F, Luboinski M, Hagege H, Dao T, Van Steenbergen W, Buffet C, Rougier P, Adler M, Pignon JP, Roche A (1998) Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial. Groupe CHC. J Hepatol 29:129–134PubMedCrossRef
3.
Zurück zum Zitat Llovet JM (2005) Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40:225–235PubMedCrossRef Llovet JM (2005) Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40:225–235PubMedCrossRef
4.
Zurück zum Zitat Uraki J, Yamakado K, Nakatsuka A, Takeda K (2004) Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: Therapeutic effects and prognostic factors. Eur J Radiol 51:12–18PubMedCrossRef Uraki J, Yamakado K, Nakatsuka A, Takeda K (2004) Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: Therapeutic effects and prognostic factors. Eur J Radiol 51:12–18PubMedCrossRef
5.
Zurück zum Zitat Bronowicki JP, Vetter D, Dumas F, Boudjema K, Bader R, Weiss AM, Wenger JJ, Boissel P, Bigard MA, Doffoel M (1994) Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients. Cancer 74:16–24PubMedCrossRef Bronowicki JP, Vetter D, Dumas F, Boudjema K, Bader R, Weiss AM, Wenger JJ, Boissel P, Bigard MA, Doffoel M (1994) Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients. Cancer 74:16–24PubMedCrossRef
6.
Zurück zum Zitat Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K (1991) Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model. Cancer 68:2150–2154PubMedCrossRef Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K (1991) Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model. Cancer 68:2150–2154PubMedCrossRef
7.
Zurück zum Zitat Cheng HY, Shou Y, Wang X, Xu AM, Chen D, Jia YC (2004) Adjustment of lipiodol dose according to tumor blood supply during transcatheter arterial chemoembolization for large hepatocellular carcinoma by multidetector helical CT. World J Gastroenterol 10:2753–2755PubMed Cheng HY, Shou Y, Wang X, Xu AM, Chen D, Jia YC (2004) Adjustment of lipiodol dose according to tumor blood supply during transcatheter arterial chemoembolization for large hepatocellular carcinoma by multidetector helical CT. World J Gastroenterol 10:2753–2755PubMed
8.
Zurück zum Zitat Huppert PE, Lauchart W, Duda SH, Torkler C, Kloska SP, Weinlich M, Benda N, Pereira P, Claussen CD (2004) Chemoembolization of hepatocellular carcinomas: Which factors determine therapeutic response and survival? Rofo 176:375–385PubMed Huppert PE, Lauchart W, Duda SH, Torkler C, Kloska SP, Weinlich M, Benda N, Pereira P, Claussen CD (2004) Chemoembolization of hepatocellular carcinomas: Which factors determine therapeutic response and survival? Rofo 176:375–385PubMed
9.
Zurück zum Zitat Poyanli A, Rozanes I, Acunas B, Sencer S (2001) Palliative treatment of hepatocellular carcinoma by chemoembolization. Acta Radiol 42:602–607PubMedCrossRef Poyanli A, Rozanes I, Acunas B, Sencer S (2001) Palliative treatment of hepatocellular carcinoma by chemoembolization. Acta Radiol 42:602–607PubMedCrossRef
10.
Zurück zum Zitat Chen MS, Li JQ, Zhang YQ, Lu LX, Zhang WZ, Yuan YF, Guo YP, Lin XJ, Li GH (2002) High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World J Gastroenterol 8:74–78PubMed Chen MS, Li JQ, Zhang YQ, Lu LX, Zhang WZ, Yuan YF, Guo YP, Lin XJ, Li GH (2002) High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World J Gastroenterol 8:74–78PubMed
11.
Zurück zum Zitat Baur M, Walter R, Gebauer A, Tscholakoff D, Lochs H, Muhlbacher F, Turetschek K, Binder R, Hudec M, Gangl A, Ferenci P, Dittrich C (2003) Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: A non-randomized prospective study. Int J Oncol 23:811–819PubMed Baur M, Walter R, Gebauer A, Tscholakoff D, Lochs H, Muhlbacher F, Turetschek K, Binder R, Hudec M, Gangl A, Ferenci P, Dittrich C (2003) Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: A non-randomized prospective study. Int J Oncol 23:811–819PubMed
12.
Zurück zum Zitat Caturelli E, Siena DA, Fusilli S, Villani MR, Schiavone G, Nardella M, Balzano S, Florio F (2000) Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: Evaluation of damage to nontumorous liver tissue-long-term prospective study. Radiology 215:123–128PubMed Caturelli E, Siena DA, Fusilli S, Villani MR, Schiavone G, Nardella M, Balzano S, Florio F (2000) Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: Evaluation of damage to nontumorous liver tissue-long-term prospective study. Radiology 215:123–128PubMed
13.
Zurück zum Zitat Harris M, Gibbs P, Cebon J, Jones R, Sewell R, Schelleman T, Angus P (2001) Hepatocellular carcinoma and chemoembolization. Intern Med J 31:517–522PubMedCrossRef Harris M, Gibbs P, Cebon J, Jones R, Sewell R, Schelleman T, Angus P (2001) Hepatocellular carcinoma and chemoembolization. Intern Med J 31:517–522PubMedCrossRef
14.
Zurück zum Zitat Huang MS, Lin Q, Jiang ZB, Zhu KS, Guan SH, Li ZR, Shan H (2004) Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma. World J Gastroenterol 10:825–829PubMed Huang MS, Lin Q, Jiang ZB, Zhu KS, Guan SH, Li ZR, Shan H (2004) Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma. World J Gastroenterol 10:825–829PubMed
15.
Zurück zum Zitat Brown KT, Nevins AB, Getrajdman GI, Brody LA, Kurtz RC, Fong Y, Blumgart LH (1998) Particle embolization for hepatocellular carcinoma. J Vasc Interv Radiol 9:822–828PubMedCrossRef Brown KT, Nevins AB, Getrajdman GI, Brody LA, Kurtz RC, Fong Y, Blumgart LH (1998) Particle embolization for hepatocellular carcinoma. J Vasc Interv Radiol 9:822–828PubMedCrossRef
16.
Zurück zum Zitat Pelage JP, Le Dref O, Beregi JP, Nonent M, Robert Y, Cosson M, Jacob D, Truc JB, Laurent A, Rymer R (2003) Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. J Vasc Interv Radiol 14:15–20PubMed Pelage JP, Le Dref O, Beregi JP, Nonent M, Robert Y, Cosson M, Jacob D, Truc JB, Laurent A, Rymer R (2003) Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. J Vasc Interv Radiol 14:15–20PubMed
17.
Zurück zum Zitat Beaujeux R, Laurent A, Wassef M, Casasco A, Gobin YP, Aymard A, Rufenacht D, Merland JJ (1996) Trisacryl gelatin microspheres for therapeutic embolization. II. Preliminary clinical evaluation in tumors and arteriovenous malformations. AJNR Am J Neuroradiol 17:541–548PubMed Beaujeux R, Laurent A, Wassef M, Casasco A, Gobin YP, Aymard A, Rufenacht D, Merland JJ (1996) Trisacryl gelatin microspheres for therapeutic embolization. II. Preliminary clinical evaluation in tumors and arteriovenous malformations. AJNR Am J Neuroradiol 17:541–548PubMed
18.
Zurück zum Zitat Spies JB, Benenati JF, Worthington-Kirsch RL, Pelage JP (2001) Initial experience with use of tris-acryl gelatin microspheres for uterine artery embolization for leiomyomata. J Vasc Interv Radiol 12:1059–1063PubMed Spies JB, Benenati JF, Worthington-Kirsch RL, Pelage JP (2001) Initial experience with use of tris-acryl gelatin microspheres for uterine artery embolization for leiomyomata. J Vasc Interv Radiol 12:1059–1063PubMed
19.
Zurück zum Zitat Basile A, Rand T, Lomoschitz F, Toma C, Lupattelli T, Kettenbach J, Lammer J (2004) Trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of bone neoplasms. Cardiovasc Intervent Radiol. 27:495–502PubMed Basile A, Rand T, Lomoschitz F, Toma C, Lupattelli T, Kettenbach J, Lammer J (2004) Trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of bone neoplasms. Cardiovasc Intervent Radiol. 27:495–502PubMed
20.
Zurück zum Zitat Joffre FTJ, Pelage JP, Groupe FEMIC (2004) FEMIC (Fibromes Embolises aux MICrospheres calibrees): Uterine fibroid embolization using tris-acryl microspheres. A French multicenter study. Cardiovasc Intervent Radiol 27:600–606PubMedCrossRef Joffre FTJ, Pelage JP, Groupe FEMIC (2004) FEMIC (Fibromes Embolises aux MICrospheres calibrees): Uterine fibroid embolization using tris-acryl microspheres. A French multicenter study. Cardiovasc Intervent Radiol 27:600–606PubMedCrossRef
21.
Zurück zum Zitat Stampfl S, Stampfl U, Rehnitz C, Schnabel Ph, Satzl S, Christoph P, Henn C, Thomas F, Richter GM (2007) Experimental evaluation of early and long-term effects of microparticle embolization in two different mini-pig models. Part 1: Kidney. CVIR 30:257–267CrossRefPubMed Stampfl S, Stampfl U, Rehnitz C, Schnabel Ph, Satzl S, Christoph P, Henn C, Thomas F, Richter GM (2007) Experimental evaluation of early and long-term effects of microparticle embolization in two different mini-pig models. Part 1: Kidney. CVIR 30:257–267CrossRefPubMed
22.
Zurück zum Zitat Kassissia I, Brault A, Huet PM (1994) Hepatic artery and portal vein vascularization of normal and cirrhotic rat liver. Hepatology 19:1189–1197PubMed Kassissia I, Brault A, Huet PM (1994) Hepatic artery and portal vein vascularization of normal and cirrhotic rat liver. Hepatology 19:1189–1197PubMed
23.
Zurück zum Zitat Tancredi T, McCuskey PA, Kan Z, Wallace S (1999) Changes in rat liver microcirculation after experimental hepatic arterial embolization: Comparison of different embolic agents. Radiology 211:177–181PubMed Tancredi T, McCuskey PA, Kan Z, Wallace S (1999) Changes in rat liver microcirculation after experimental hepatic arterial embolization: Comparison of different embolic agents. Radiology 211:177–181PubMed
24.
Zurück zum Zitat Kan Z, Ivancev K, Lunderquist A, McCuskey PA, Wright KC, Wallace S, McCuskey RS (1993) In vivo microscopy of hepatic tumors in animal models: A dynamic investigation of blood supply to hepatic metastases. Radiology 187:621–626PubMed Kan Z, Ivancev K, Lunderquist A, McCuskey PA, Wright KC, Wallace S, McCuskey RS (1993) In vivo microscopy of hepatic tumors in animal models: A dynamic investigation of blood supply to hepatic metastases. Radiology 187:621–626PubMed
25.
Zurück zum Zitat Ackerman NB (1974) The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 75:589–596PubMed Ackerman NB (1974) The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 75:589–596PubMed
26.
Zurück zum Zitat Itsubo M, Koike K, Tsuno S, Osada M, Komuro O, Shimada N, Okuda J, Fukada H, Okuaki Y, Kawabe T, Toda G (2002) Subsegmental transcatheter arterial embolization for small hepatocellular carcinoma. Hepatogastroenterology 49:735–739PubMed Itsubo M, Koike K, Tsuno S, Osada M, Komuro O, Shimada N, Okuda J, Fukada H, Okuaki Y, Kawabe T, Toda G (2002) Subsegmental transcatheter arterial embolization for small hepatocellular carcinoma. Hepatogastroenterology 49:735–739PubMed
27.
Zurück zum Zitat Takayasu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M, Hasegawa H, Hirohashi S (1987) Hepatocellular carcinoma: Treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 163:345–351PubMed Takayasu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M, Hasegawa H, Hirohashi S (1987) Hepatocellular carcinoma: Treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 163:345–351PubMed
28.
Zurück zum Zitat Lee JK, Chung YH, Song BC, Shin JW, Choi WB, Yang SH, Yoon HK, Sung KB, Lee YS, Suh DJ (2002) Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. J Gastroenterol Hepatol 17:52–58PubMedCrossRef Lee JK, Chung YH, Song BC, Shin JW, Choi WB, Yang SH, Yoon HK, Sung KB, Lee YS, Suh DJ (2002) Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. J Gastroenterol Hepatol 17:52–58PubMedCrossRef
29.
Zurück zum Zitat Chung YH (2005) A strategy for early detection of recurrent hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. Intervirology 48:46–51PubMedCrossRef Chung YH (2005) A strategy for early detection of recurrent hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. Intervirology 48:46–51PubMedCrossRef
30.
Zurück zum Zitat Ikeda M, Maeda S, Shibata J, Muta R, Ashihara H, Tanaka M, Fujiyama S, Tomita K (2004) Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma. Oncology 66:24–31PubMedCrossRef Ikeda M, Maeda S, Shibata J, Muta R, Ashihara H, Tanaka M, Fujiyama S, Tomita K (2004) Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma. Oncology 66:24–31PubMedCrossRef
31.
Zurück zum Zitat Rand T LC, Schoder M, Schmook MT, Peck-Radosavljevic M, Kettenbach J, Wolf FSB, Lammer J (2005) Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate. Cardiovasc Intervent Radiol 28:313–318PubMedCrossRef Rand T LC, Schoder M, Schmook MT, Peck-Radosavljevic M, Kettenbach J, Wolf FSB, Lammer J (2005) Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate. Cardiovasc Intervent Radiol 28:313–318PubMedCrossRef
32.
Zurück zum Zitat Yu JS, Kim KW, Jeong MG, Lee DH, Park MS, Yoon SW (2002) Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy. Cardiovasc Intervent Radiol 25:270–274PubMedCrossRef Yu JS, Kim KW, Jeong MG, Lee DH, Park MS, Yoon SW (2002) Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy. Cardiovasc Intervent Radiol 25:270–274PubMedCrossRef
33.
Zurück zum Zitat Huang XQ, Huang ZQ, Duan WD, Zhou NX, Feng YQ (2002) Severe biliary complications after hepatic artery embolization. World J Gastroenterol 8:119–123PubMed Huang XQ, Huang ZQ, Duan WD, Zhou NX, Feng YQ (2002) Severe biliary complications after hepatic artery embolization. World J Gastroenterol 8:119–123PubMed
34.
Zurück zum Zitat Kim HK, Chung YH, Song BC, Yang SH, Yoon HK, Yu E, Sung KB, Lee YS, Lee SG, Suh DJ (2001) Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 32:423–427PubMedCrossRef Kim HK, Chung YH, Song BC, Yang SH, Yoon HK, Yu E, Sung KB, Lee YS, Lee SG, Suh DJ (2001) Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 32:423–427PubMedCrossRef
35.
Zurück zum Zitat Koniaris LG, Seibel JA, Geschwind JF, Sitzmann JV (2003) Can ethanol therapies injure the bile ducts? Hepatogastroenterology 50:69–72PubMed Koniaris LG, Seibel JA, Geschwind JF, Sitzmann JV (2003) Can ethanol therapies injure the bile ducts? Hepatogastroenterology 50:69–72PubMed
36.
Zurück zum Zitat Brown KT (2004) Fatal pulmonary complications after arterial embolization with 40–120 μm tris-acryl gelatin microspheres. J Vasc Interv Radiol 15:197–200PubMed Brown KT (2004) Fatal pulmonary complications after arterial embolization with 40–120 μm tris-acryl gelatin microspheres. J Vasc Interv Radiol 15:197–200PubMed
37.
Zurück zum Zitat Stridbeck H, Lorelius LE (1985) Liver necrosis after hepatic dearterialization in pigs. Cardiovasc Intervent Radiol 8:50–53PubMedCrossRef Stridbeck H, Lorelius LE (1985) Liver necrosis after hepatic dearterialization in pigs. Cardiovasc Intervent Radiol 8:50–53PubMedCrossRef
38.
Zurück zum Zitat Rand T, Loewe C, Schoder M, Schmook MT, Peck-Radosavljevic M, Kettenbach J, Wolf F, Schneider B, Lammer J (2005) Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate. Cardiovasc Intervent Radiol 28:313–318PubMedCrossRef Rand T, Loewe C, Schoder M, Schmook MT, Peck-Radosavljevic M, Kettenbach J, Wolf F, Schneider B, Lammer J (2005) Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate. Cardiovasc Intervent Radiol 28:313–318PubMedCrossRef
Metadaten
Titel
Experimental Evaluation of Early and Long-Term Effects of Microparticle Embolization in Two Different Mini-Pig Models. Part II: Liver
verfasst von
S. Stampfl
U. Stampfl
C. Rehnitz
Ph. Schnabel
S. Satzl
P. Christoph
C. Henn
F. Thomas
G. M. Richter
Publikationsdatum
01.06.2007
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 3/2007
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-005-0350-3

Weitere Artikel der Ausgabe 3/2007

CardioVascular and Interventional Radiology 3/2007 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.